BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34231490)

  • 1. Long-term antithyroid drug therapy.
    Cooper DS
    Curr Opin Endocrinol Diabetes Obes; 2021 Oct; 28(5):510-516. PubMed ID: 34231490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
    Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
    Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term outcome of patients treated with antithyroid drugs, radioactive iodine or surgery for persistent or relapsed Graves' disease.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Liu SYW; Lam CLK; Lang BHH
    Br J Surg; 2022 Mar; 109(4):381-389. PubMed ID: 35136950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term antithyroid drugs versus radioactive iodine or surgery for Graves' disease: A review of the literature.
    El Kawkgi OM; Ross DS; Stan MN
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):3-12. PubMed ID: 33283314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and Management of Children with Thyrotoxicosis.
    Leung AKC; Leung AAC
    Recent Pat Endocr Metab Immune Drug Discov; 2017; 11(1):22-31. PubMed ID: 29589552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
    Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An optimal treatment for pediatric Graves' disease is radioiodine.
    Rivkees SA; Dinauer C
    J Clin Endocrinol Metab; 2007 Mar; 92(3):797-800. PubMed ID: 17341574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term thionamide antithyroid treatment of Graves' disease.
    Azizi F; Abdi H; Amouzegar A; Habibi Moeini AS
    Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101631. PubMed ID: 35440398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive treatment of Graves' disease in children and adolescents.
    Król A; Czarniecka A; Jarząb B
    Endokrynol Pol; 2021; 72(6):661-665. PubMed ID: 34855196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs.
    Koornstra JJ; Kerstens MN; Hoving J; Visscher KJ; Schade JH; Gort HB; Leemhuis MP
    Neth J Med; 1999 Nov; 55(5):215-21. PubMed ID: 10593131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study.
    Fung MHM; Lang BHH
    Eur Radiol; 2023 Sep; 33(9):6534-6544. PubMed ID: 37036479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, management and outcomes of Graves' disease-real life data.
    Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP
    Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' disease in children and adolescents: response to long-term treatment.
    Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M
    Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort.
    Jin M; Jang A; Kim CA; Kim TY; Kim WB; Shong YK; Jeon MJ; Kim WG
    Eur Thyroid J; 2023 Apr; 12(2):. PubMed ID: 36826832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of Graves disease.
    Streetman DD; Khanderia U
    Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of antithyroid medication and radioiodine therapy in pediatric Graves' disease.
    Leu SW; Chi CS; Shu SG
    Acta Paediatr Taiwan; 2003; 44(4):220-6. PubMed ID: 14674226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
    Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.